Profil
John M.
Rothman is Chief Scientific Officer at Rize Oncology, Inc. since 2025.
Former positions include Senior Director at Schering-Plough Canada, Inc., EVP-Clinical & Scientific Operations at Advaxis, Inc. from 2011 to 2013, Chief Scientific Officer at Racura Oncology Ltd., and Executive Vice President-Product Development at Tyme Technologies, Inc. from 2020 to 2022.
Education includes a doctorate from Tulane University School of Medicine.
Postes actifs de John Rothman
| Sociétés | Poste | Début |
|---|---|---|
| RIZE ONCOLOGY INC. | Directeur Technique/Scientifique/R&D | 09/01/2025 |
Anciens postes connus de John Rothman
| Sociétés | Poste | Fin |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/02/2022 |
| RACURA ONCOLOGY LTD | Directeur Technique/Scientifique/R&D | 01/10/2019 |
| AYALA PHARMACEUTICALS, INC. | Directeur des opérations | 09/12/2011 |
Schering-Plough Canada, Inc.
Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Directeur/Membre du Conseil | - |
Formation de John Rothman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Schering-Plough Canada, Inc.
Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Health Technology |
Tulane University School of Medicine
Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
GeneTether Therapeutics, Inc.
GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
















